Clinical Trial Update: Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating interferon alfa-2b for melanoma with early lymph node metastasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Intron A (interferon alfa-2b) (interferon alfa-2b)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Melanoma (Skin) | Phase 3 | Status: COMPLETED